ALX-001

N/A

Report date: 2024/05/11 18:35:16
NME

Base Information

Drug NameALX-001
Drug Alias NameBMS-984923BMS984923BMS-9894923ALX-001ALX001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMetabotropic glutamate receptor 5 modulators
TargetsMetabotropic glutamate receptor 5
Therapy Area/IndicationsDrug-Related Side Effects and Adverse ReactionsAlzheimer DiseaseDementia +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Active CompaniesAllyx Therapeutics IncNational Institutes Of HealthYale University +[4] 
Inactive CompaniesN/A
Active IndicationsDrug-Related Side Effects and Adverse ReactionsAlzheimer DiseaseDementia +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A